Finance Director – Leo Boelaarts (Netherlands)
Leo Boelaarts, born August 16th 1959 in Rotterdam, the Netherlands.
|1988||MSc in Psychology and Medicine.|
|1993-1996||Executive Board Member of the Dutch Junior Society of Geriatric Medicine. |
|1996-1997||President of the Dutch Junior Society of Geriatric Medicine.|
Consultant Geriatric Medicine in the Leyenburg Hospital, the Hague.
Consultant Geriatric Medicine in Medical Centre Alkmaar, Alkmaar.
|Medical Manager of the Department of Geriatric Medicine.|
|1998-2003||Executive Board Member of the Dutch Society of Geriatric Medicine.|
|2002-2011||Full Board Member of the European Union Medical Specialists (EUMS)-Geriatric Medicine Section.|
|2002-2011||Full Board Member of the European Union Geriatric Medicine Society (EUGMS).|
|2011||Preparation and presentation for the Full Board of the Bid book for the EUGMS congress in 2013 and 2014.|
|2007-||Head of the Teaching Programme for MD’s in Geriatric Medicine in Medical Centre Alkmaar, a large Teaching Hospital in Alkmaar. |
As a member of the MCA Central Training Committee he is actively participating in education programmes for medical students, residents and fellows in training, GP’s and nurses.
His (PhD) research focuses on characterizing and diagnosing elderly patients in a geriatric memory outpatient clinic using biomarkers.
He was Principal Investigator in a number of Phase III Pharmaceutical trials in Alzheimers Disease. Presently he is co-investigator in a Dutch multicenter trial on the profylactic effect of haldol on the incidence of delirium in acutely admitted patients (the HARPOON trial), co-investigatior in a Dutch multicenter trial on the efficacy of Souvenaid, a medical food developed for the treatment of Alzheimer’s disease (AWARE study), and co-investigator in a Dutch multicenter trial on the use of MRI and CSF in a real life multicenter local memory clinics cohort, a substudy of the ABIDE national project (Alzheimer’s Biomarkers in Daily Practice).
He frequently participates as a speaker in meetings to inform dementia patients and their caregivers.